BCLI - Brainstorm Cell Therapeutics Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart

BCLI - Brainstorm Cell Therapeutics Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Brainstorm Cell Therapeutics Price Target & Analyst ... Oct 28, 2019 · 1 Wall Street analysts have issued ratings and price targets for Brainstorm Cell Therapeutics in the last 12 months. Their average twelve-month price target is $9.00, suggesting that the stock has a possible upside of 103.62%. The high price target for BCLI is $9.00 and the low price target for BCLI is $9.00. Brainstorm Cell Therapeutics Inc (BCLI) Quote | Morningstar Brainstorm Cell Therapeutics Inc. BCLI Morningstar Rating Rating as of Mar 31, 2020. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation BCLI Stock Quote - Brainstorm Cell Therapeutics, Inc ... Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease

Brainstorm Cell Therapeutics Inc. (BCLI) Company Bio Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders. The company was founded in 2000 and is based in Hackensack, New Jersey.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive … Investors & Media - Brainstorm Cell Therapeutics Inc. The Investor Relations website contains information about Brainstorm Cell Therapeutics Inc.'s business for stockholders, potential investors, and financial analysts. Investors & Media - Brainstorm Cell Therapeutics Inc. BCLI | Stock Snapshot - Fidelity

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on 

Brainstorm Cell Therapeutics Inc. (BCLI) Company Bio Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders. The company was founded in 2000 and is based in Hackensack, New Jersey. Brainstorm Cell Therapeutics - BCLI - Stock Price & News ... Real time Brainstorm Cell Therapeutics (BCLI) stock price quote, stock graph, news & analysis. BCLI - Stock quote for BRAINSTORM CELL THERAPEUTICS INC ... View the latest BCLI stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of BRAINSTORM CELL THERAPEUTICS INC.. Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Real ...

Learn about BCLI with our data and independent analysis including price, star rating, Brainstorm Cell Therapeutics Inc Stocks by Morningstar Classification  

6 Mar 2020 BrainStorm Cell Therapeutics Inc., (NASDAQ: BCLI), a leading and sale of 1,250,000 shares of common stock at a price per share of $8.00,  BCLI / BrainStorm Cell Therapeutics Inc. - Institutional Ownership and Shareholders File Date, Form, Investor, Opt, Avg Share Price, Shares, Shares Changed

View the latest Brainstorm Cell Therapeutics Inc. (BCLI) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Get breaking news and analysis on Brainstorm Cell Therapeutics Inc. (BCLI) stock, price quote and chart, trading and investing tools. Brainstorm Cell Therapeutics In (BCLI) Stock Forum ... ALS is a debilitating and fatal neurodegenerative condition for which there is no effective treatment. Based on BrainStorm Cell Therapeutics’ scientific and early phase clinical trial data, CIRM awarded them $15.9 million to advance their investigational therapy NurOwn into a Phase 3 trial. BrainStorm Cell Therapeutics Inc BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, publicly-traded biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. - TheStreet

Brainstorm Cell Therapeutics Inc. BCLI 4.89 0.08 (1.66%). NASDAQUpdated Apr 7, 2020 9:26 PM. 3,238. Watchers. Watch. Filter by: Real-Time  Researching Brainstorm Cell Therapeutics (NASDAQ:BCLI) stock? View BCLI's stock price, price target, earnings, financials, forecast, insider trades, news, and  Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View the latest Brainstorm Cell Therapeutics Inc. (BCLI) stock price, news, historical charts, analyst ratings and financial information from WSJ. BCLI: Get the latest Brainstorm Cell Therapeutics stock price and detailed information including BCLI news, historical charts and realtime prices. Stock analysis for BrainStorm Cell Therapeutics Inc (BCLI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and  Get today's Brainstorm Cell Therapeutics Inc stock price and latest BCLI news as well as Brainstorm Cell Therapeutics real-time stock quotes, technical analysis,